Dividend2 May 2026, 04:00 pm
Epigral Ltd Approves FY26 Results & ₹5 Dividend
AI Summary
Epigral Ltd's Board of Directors approved the audited standalone and consolidated financial results for the fourth quarter and year ended March 31, 2026. The board also recommended a final dividend of ₹5.00 (50%) per equity share of face value ₹10 each for the financial year 2025-26. The audit report, issued by M/s. S R B C & CO LLP, had an unmodified opinion on the financial statements. The board meeting was held on May 2, 2026.
Key Highlights
- Approved audited financial results for Q4 and year ended March 31, 2026.
- Recommended a final dividend of ₹5.00 per equity share.
- M/s. S R B C & CO LLP issued an audit report with an unmodified opinion.
- Meeting commenced at 12:45 p.m. and concluded at 2.45 p.m. on May 2, 2026.
Price Impact
More from MFL